Elizabeth O’Hearn

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity

Elizabeth O’Hearn, Giuseppe Battaglia, EB De Souza et al. · Journal of Neuroscience · 1988 · 546 citations · Full text

Pharmacy, Neuroscience, Pharmacology +17

3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.

Giuseppe Battaglia, S.Y. Yeh, Elizabeth O’Hearn et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 459 citations

Medicine, Neuroscience, Pharmacology +16

A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease–like 2

Susan E. Holmes, Elizabeth O’Hearn, Adam Rosenblatt et al. · Nature Genetics · 2001 · 284 citations

Life Sciences, Genetics, Molecular Genetics +13

Organization of raphe-cortical projections in rat: A quantitative retrograde study

Elizabeth O’Hearn, Mark E. Molliver · Brain Research Bulletin · 1984 · 248 citations

Life Sciences, Neurobiology, Neuroscience +13

Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5‐HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives

Laura A. Mamounas, Crystal A. Mullen, Elizabeth O’Hearn et al. · The Journal of Comparative Neurology · 1991 · 237 citations

Medicine, Neuroscience, Pharmacology +17